ETFChannel.com
ETF Introduction: IHE — iShares U.S. Pharmaceuticals ETF
Market News Video - Monday, April 6, 5:28 PM

Description to the Dow Jones U:S. Pharmaceuticals Index Fund, traded under ticker symbol IHE. This ETF is a fund, created in May 2006, that corresponds to the price and yield performance, before fees and expenses, of the Dow Jones United States Select Pharmaceuticals Index. The underlying index gauges the performance of pharma companies in the US equities markets including drug manufacturers, but excluding vitamin producing companies.

Fund Name:
iShares U.S. Pharmaceuticals ETF
Issuer:
iShares
Total Net Assets:
$401,294,934
Inception:
NA
Related Index:
Dow Jones U.S. Select Pharmaceuticals Index ($DJSPHM)
ETF Category: 
Health
Expense Ratio: 
0.39% 
Net Asset Value: 
$174.48  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
IHE.NV  
Number of Holdings: 
42  
Annualized Yield: 
1.73%  
Annualized Distribution: 
3.010  
IHE Dividend History » 
Stock Weight Amount
Johnson & Johnson 22.59% $90,645,805
Pfizer 18.07% $72,531,030
Eli Lilly 4.73% $18,998,771
Bristol Myers Squibb 4.63% $18,576,342
Merck & Co. 4.57% $18,328,394
List of all 46 stocks held by IHE »
Quotes delayed 20 minutes

Email EnvelopeFree IHE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.18 out of 4)
28th percentile
(ranked lower than approx. 72% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
ETF Assets
IVV   $282,773,420,847
IEFA   $80,270,497,875
AGG   $78,903,173,973
IJR   $62,610,874,188
IEMG   $59,242,806,316
List of all 316 others »
Shares Short 3,828
Chg. from Last Month +617
Shares Outstanding 2,250,000
% of Shares Short 0.17%
Days to Cover 0.5
Based on third party short interest data.

IHE | iShares U.S. Pharmaceuticals ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.